Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?

Canopy Growth and Tilray Brands are two major players in the healthcare sector, with Canopy focusing on the U.S. market and Tilray diversifying into beverages. Both companies have seen significant changes in their financial profiles, with Canopy reporting a net loss of $1.7 billion in its fiscal 2022 and Tilray reporting a net loss of $349.2 million in its fiscal 2022. Analysts suggest that Tilray's diversified business model may provide more stability in the long term, but Canopy's focus on the U.S. market could lead to significant growth if federal cannabis legalization occurs.